Furthermore, gemcitabine combined with local injections of CXCL13 and CCL21 into tumors in a murine model of pancreatic cancer-induced TLSs enhanced CD8+ T cell infiltration, decreased FOXP3+ regulatory T cells, and reduced tumor size compared to the vehicle-treated group [45]. Here, CXCL13 is linked to neoplasm.